H19 and breast cancer: In summary, aiming to further understanding of molecular mechanisms of chemoresistance in breast cancer, we have demonstrated in the present study that H19 lncRNA was significantly upregulated in Dox-resistant breast cancer cells, which contributed to the cell resistance of multiple chemotherapeutic agents.